Barry Weiner | President, Principal Accounting Officer and CFO |
Jim O'Brien | EVP, Finance |
Kevin Ellich | Craig-Hallum |
Robert Gold | Gold Capital Management |
Robert Smith | Center for Performance Investing |
Good morning and welcome to the Enzo Biochem Inc.
Second Quarter 2018 Operating Results Conference Call. I will now read the company's Safe Harbor statement. Except for historical information, the matters discussed in this news release may be considered forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 as amended, and Section 21E of the Securities Exchange Act of 1934 as amended. Such statements include declarations regarding the intent, belief or current expectations of the company and its management, including those related to cash flow, gross margins, revenues and expenses are dependent on a number of factors outside of the control of the company, including inter alia, the market for the company's products and services, cost of goods and services, other expenses, government regulations, and litigations and general business conditions.